Variation in neoadjuvant chemotherapy utilization for epithelial ovarian cancer at high volume hospitals in the United States and associated survival

Highlights • Neoadjuvant chemotherapy use varied widely, from 5 to 55%, among high volume hospitals. • Hospital level patterns of neoadjuvant chemotherapy use are associated with survival. • Hospitals with low neoadjuvant chemotherapy utilization had decreased survival.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gynecologic oncology 2017-06, Vol.145 (3), p.500-507
Hauptverfasser: Barber, Emma L, Dusetzina, Stacie B, Stitzenberg, Karyn B, Rossi, Emma C, Gehrig, Paola A, Boggess, John F, Garrett, Joanne M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights • Neoadjuvant chemotherapy use varied widely, from 5 to 55%, among high volume hospitals. • Hospital level patterns of neoadjuvant chemotherapy use are associated with survival. • Hospitals with low neoadjuvant chemotherapy utilization had decreased survival.
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2017.03.014